SSRI medication use during pregnancy may increase the risk for GD and some poor newborn outcomes, but may protect against adverse outcomes.

Adam Urato, who is currently a vaccine advisor to the CDC, is closely associated with acting CDER director Tracy Beth Høeg ...

LOS ANGELES — The novel norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI) centanafadine (Otsuka Pharmaceutical Co., Ltd.) is effective and ...

Immediately following Robert F. Kennedy Jr.’s confirmation as health secretary, President Donald Trump instructed his administration to assess the “threat” posed to children by the prescription of ...

In the first directive since his nomination to secretary of health and human services, Robert F. Kennedy Jr. thrust psychiatric medications and their use among children into the national spotlight.

Synendos Therapeutics AG has received approval from the European Medicines Agency (EMA) to initiate a first-in-human trial of its lead asset, SYT-510, a first-in-class inhibitor that modulates a newly ...

A research team led by Professor Oh Yong-Seok of the Department of Brain Sciences at the Daegu Gyeongbuk Institute of Science ...

Another phase III failure of Theravance Biopharma Inc.’s norepinephrine reuptake inhibitor ampreloxetine to treat symptomatic neurogenic orthostatic hypotension, this time in patients with the rare ...